Shoulder implant under the microscope: 10-Year safety study launches

NCT ID NCT04003272

ENROLLING_BY_INVITATION Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 59 people who received a specific shoulder implant (Versa-Dial Reverse Ti Glenosphere) to see how safe and effective it is over up to 10 years. Participants have shoulder arthritis, fractures, or a failed previous replacement. Researchers track complications, revisions, and patient-reported outcomes like pain and function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHOULDER ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis Shoulder Fractures Shoulder Injuries Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SHOULDER ARTHRITIS SHOULDER DISEASE SHOULDER FRACTURES SHOULDER INJURIES SHOULDER PAIN

Contacts and locations

Locations

Norton Orthopaedic and Sports Medicine

Louisville, Kentucky, 40241, United States
University of Buffalo

Buffalo, New York, 14215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.